206 related articles for article (PubMed ID: 18821068)
1. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
2. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
3. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
Ramsey BW; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Kravitz RM; Schidlow DV; Wilmott RW; Astley SJ; McBurnie MA
N Engl J Med; 1993 Jun; 328(24):1740-6. PubMed ID: 8497284
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
Murphy TF
Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
[TBL] [Abstract][Full Text] [Related]
9. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
10. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
12. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
[TBL] [Abstract][Full Text] [Related]
13. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
Quintana-Gallego E; Lopez-Campos JL; Calero C; Dapena FJ
Med Clin (Barc); 2014 Jan; 142(2):59-63. PubMed ID: 23369499
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis.
Iles R; Legh-Smith J; Drummond M; Prevost A; Vowler S
J Cyst Fibros; 2003 Sep; 2(3):120-8. PubMed ID: 15463860
[TBL] [Abstract][Full Text] [Related]
15. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
17. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
18. The effect of dithiothreitol on chemotactic factors in induced sputum of chronic obstructive pulmonary disease patients.
Wang F; He B
Respiration; 2009; 78(2):217-22. PubMed ID: 19439918
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
20. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease.
Martínez-Solano L; Macia MD; Fajardo A; Oliver A; Martinez JL
Clin Infect Dis; 2008 Dec; 47(12):1526-33. PubMed ID: 18990062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
